Epilepsy Trial, Recruiting NCT06492720 Sponsor: NaviFUS Corporation Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06492720
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have epilepsy that has not been controlled despite trying at least 3 different seizure medications, and you are currently taking 1 to 4 seizure medications
  • Doctors have already done thorough testing to identify where in the brain your seizures are starting
  • You have had at least 4 seizures that are clearly visible or significantly disabling during an 8-week observation period, with at least one seizure per month during that time
  • You are willing and able to give written consent and follow the study plan throughout the trial

Who may not be able to join:

  • You have an active mental health or mood disorder that doctors believe would interfere with taking part in the study
  • You have a pacemaker, heart defibrillator, permanent medication pump, cochlear implant, or deep brain stimulator already implanted
  • The area of your scalp or skull where the treatment would be applied has scars, skin conditions (such as eczema), wounds, or thinning of the scalp
  • There is a calcium deposit (calcification) detected by imaging in the path of the treatment
  • Your blood does not clot normally, based on specific blood test results, or you take blood-thinning medications (confirm with trial site)
  • You are pregnant or breastfeeding
  • You have other serious health problems that would make it hard to follow the study requirements
  • You have a known allergy to MRI contrast dye, or you have metal implants that are not safe for MRI scans
  • You currently use recreational drugs, have a history of drug addiction, or have a known history of alcohol or substance abuse
  • You have taken part in another clinical trial involving an experimental drug or device within the past 4 weeks
  • Your seizure medications have been changed during the initial observation/screening period
  • Your vagus nerve stimulator (a device used to help control seizures) settings were changed within 2 months before the start of the observation period
  • You have had a specific brain procedure called radiofrequency thermocoagulation within 2 months before the start of the observation period
  • Your IQ score is below 70, based on a specific standardised intelligence test
  • Any other condition that the study doctor feels would make participation unsuitable or unsafe for you (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02-25860560

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
NaviFUS Corporation
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Changes of seizure frequency after treatment compared to baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov